共 130 条
[31]
Dorkin HL(2001)Comparison of inhibitory and bactericidal activity of antipseudomonal antibiotics against Chest 120 107S-41
[32]
Eisenberg JD(1994) isolates from cystic fibrosis patients J Antimicrob Chemother 34 331-78
[33]
Stephens D(1987)Development of antibiotic resistance in J Antimicrob Chemother 19 569-7
[34]
Garey N(1989) during two decades of antipseudomonal treatment at the Danish CF Center Antimicrob Agents Chemother 33 41-45
[35]
Isles A(1993)Resistance surveillance programs and the incidence of gram-negative bacillary resistance to amikacin from 1967 to 1985 J Clin Invest 91 38-42
[36]
Weber A(1997)Aminoglycoside resistance: a worldwide perspective Can J Infect Dis 8 335-26
[37]
Williams-Warren J(2002) activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Chest 122 219-7
[38]
Ramsey B(2001) isolated from cystic fibrosis patients in southwestern Germany J Pediatr 139 572-9
[39]
Touw DJ(2003)Long-term benefits of inhaled tobramycin in adolescent patients with cystic fibrosis Am J Respir Crit Care Med 167 841-64
[40]
Jacobs FAH(2002)Administration of aerosolized antibiotics in cystic fibrosis patients Eur Respir J 20 658-51